Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)

BACKGROUND: High‐dose pharmaceutical‐grade biotin (MD1003) has positive effects on disability in progressive multiple sclerosis (PMS), but its mechanism of action remains unclear. The objective of our study was to quantify the effect of MD1003 in patients with PMS, using clinical response, plasma ne...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Brain Behav
Main Authors: Collongues, Nicolas, Kuhle, Jens, Tsagkas, Charidimos, Lamy, Julien, Meyer, Nicolas, Barro, Christian, Parmar, Katrin, Amann, Michael, Wuerfel, Jens, Kappos, Ludwig, Moreau, Thibault, de Seze, Jerome
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7882156/
https://ncbi.nlm.nih.gov/pubmed/33314801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1998
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker